• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性冠状动脉综合征患者死亡率风险计算工具的短期和长期性能

Short- and long-term performance of risk calculation tools for mortality in patients with acute coronary syndrome.

作者信息

Aizawa Takatoku, Nagao Tomoaki, Oda Yusuke, Nakano Suguru, Ito Kazuki, Shirai Yusuke, Hosoya Natsuko, Sawasaki Kohei, Arai Junji, Fujita Shinya, Muto Masahiro, Oda Teiji, Maekawa Yuichiro

机构信息

Department of Cardiology, Hamamatsu Medical Center, Hamamatsu, Japan.

Division of Cardiology, Department of Internal Medicine Ⅲ, Hamamatsu University of Medicine, Hamamatsu, Japan.

出版信息

Front Cardiovasc Med. 2024 May 28;11:1388686. doi: 10.3389/fcvm.2024.1388686. eCollection 2024.

DOI:10.3389/fcvm.2024.1388686
PMID:38867848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11168304/
Abstract

BACKGROUND

The mortality rate of acute coronary syndrome (ACS) remains high. Therefore, patients with ACS should undergo early risk stratification, for which various risk calculation tools are available. However, it remains uncertain whether the predictive performance varies over time between risk calculation tools for different target periods. This study aimed to compare the predictive performance of risk calculation tools in estimating short- and long-term mortality risks in patients with ACS, while considering different observation periods using time-dependent receiver operating characteristic (ROC) analysis.

METHODS

This study included 404 consecutive patients with ACS who underwent coronary angiography at our hospital from March 2017 to January 2021. The ACTION and GRACE scores for short-term risk stratification purposes and CRUSADE scores for long-term risk stratification purposes were calculated for all participants. The participants were followed up for 36 months to assess mortality. Using time-dependent ROC analysis, we evaluated the area under the curve (AUC) of the ACTION, CRUSADE, and GRACE scores at 1, 6, 12, 24, and 36 months.

RESULTS

Sixty-six patients died during the observation periods. The AUCs at 1, 6, 12, 24, and 36 months of the ACTION score were 0.942, 0.925, 0.889, 0.856, and 0.832; those of the CRUSADE score were 0.881, 0.883, 0.862, 0.876, and 0.862; and those of the GRACE score 0.949, 0.928, 0.888, 0.875, and 0.860, respectively.

CONCLUSIONS

The ACTION and GRACE scores were excellent risk stratification tools for mortality in the short term. The prognostic performance of each risk score was almost similar in the long term, but the CRUSADE score might be a superior risk stratification tool in the longer term than 3 years.

摘要

背景

急性冠状动脉综合征(ACS)的死亡率仍然很高。因此,ACS患者应进行早期风险分层,有多种风险计算工具可供使用。然而,不同目标时期的风险计算工具之间的预测性能是否随时间变化仍不确定。本研究旨在使用时间依赖性受试者工作特征(ROC)分析,比较风险计算工具在估计ACS患者短期和长期死亡风险方面的预测性能,同时考虑不同的观察期。

方法

本研究纳入了2017年3月至2021年1月在我院接受冠状动脉造影的404例连续ACS患者。为所有参与者计算用于短期风险分层的ACTION和GRACE评分以及用于长期风险分层的CRUSADE评分。对参与者进行36个月的随访以评估死亡率。使用时间依赖性ROC分析,我们评估了ACTION、CRUSADE和GRACE评分在1、6、12、24和36个月时的曲线下面积(AUC)。

结果

66例患者在观察期内死亡。ACTION评分在1、6、12、24和36个月时的AUC分别为0.942、0.925、0.889、0.856和0.832;CRUSADE评分的AUC分别为0.881、0.883、0.862、0.876和0.862;GRACE评分的AUC分别为0.949、0.928、0.888、0.875和0.860。

结论

ACTION和GRACE评分是短期死亡率的优秀风险分层工具。各风险评分的长期预后性能几乎相似,但CRUSADE评分在超过3年的长期可能是更好的风险分层工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c35/11168304/e4cc6badc341/fcvm-11-1388686-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c35/11168304/bff9a7d0cf60/fcvm-11-1388686-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c35/11168304/32b12518961c/fcvm-11-1388686-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c35/11168304/c926fb9d2a5e/fcvm-11-1388686-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c35/11168304/e4cc6badc341/fcvm-11-1388686-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c35/11168304/bff9a7d0cf60/fcvm-11-1388686-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c35/11168304/32b12518961c/fcvm-11-1388686-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c35/11168304/c926fb9d2a5e/fcvm-11-1388686-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c35/11168304/e4cc6badc341/fcvm-11-1388686-g004.jpg

相似文献

1
Short- and long-term performance of risk calculation tools for mortality in patients with acute coronary syndrome.急性冠状动脉综合征患者死亡率风险计算工具的短期和长期性能
Front Cardiovasc Med. 2024 May 28;11:1388686. doi: 10.3389/fcvm.2024.1388686. eCollection 2024.
2
Risk stratification in acute coronary syndrome: Evaluation of the GRACE and CRUSADE scores in the setting of a tertiary care centre.急性冠状动脉综合征的危险分层:在三级护理中心评估 GRACE 和 CRUSADE 评分。
Int J Clin Pract. 2020 Feb;74(2):e13444. doi: 10.1111/ijcp.13444. Epub 2019 Nov 22.
3
Comparison of the Global Registry of Acute Coronary Events Risk Score Versus the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse outcomes With Early Implementation of the ACC/AHA Guidelines Risk Score to Predict In-Hospital Mortality and Major Bleeding in Acute Coronary Syndromes.全球急性冠状动脉事件注册风险评分与“能否通过早期实施美国心脏病学会/美国心脏协会指南对不稳定型心绞痛患者进行快速风险分层以抑制不良结局”风险评分对急性冠状动脉综合征患者院内死亡率和大出血预测能力的比较
Am J Cardiol. 2016 Apr 1;117(7):1047-54. doi: 10.1016/j.amjcard.2015.12.048. Epub 2016 Jan 14.
4
Improving risk stratification in non-ST-segment elevation myocardial infarction with combined assessment of GRACE and CRUSADE risk scores.通过综合评估GRACE和CRUSADE风险评分改善非ST段抬高型心肌梗死的风险分层
Arch Cardiovasc Dis. 2014 Dec;107(12):681-9. doi: 10.1016/j.acvd.2014.06.008. Epub 2014 Sep 11.
5
Additive value of the CRUSADE score to the GRACE score for mortality risk prediction in patients with acute coronary syndromes.CRUSADE 评分对 GRACE 评分在急性冠状动脉综合征患者死亡率风险预测中的附加价值。
Int J Cardiol. 2017 Oct 15;245:1-5. doi: 10.1016/j.ijcard.2017.07.095. Epub 2017 Aug 2.
6
[Predictive value of the GRACE discharge score on the long-term out-of-hospital coronary thrombotic events after implantation of drug-eluting stents].[GRACE出院评分对药物洗脱支架植入术后长期院外冠状动脉血栓形成事件的预测价值]
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Mar 24;46(3):187-191. doi: 10.3760/cma.j.issn.0253-3758.2018.03.004.
7
Predictive performance of HAS-BLED risk score for long-term survival in patients with non-ST elevated myocardial infarction without atrial fibrillation.HAS-BLED风险评分对无房颤的非ST段抬高型心肌梗死患者长期生存的预测性能
J Cardiol. 2017 Jan;69(1):136-143. doi: 10.1016/j.jjcc.2016.02.005. Epub 2016 Mar 4.
8
[Comparison of the predictive value of the modified CADILLAC, GRACE and TIMI risk scores for the risk of short-term death in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention].[改良CADILLAC、GRACE和TIMI风险评分对急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后短期死亡风险的预测价值比较]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Mar;35(3):299-304. doi: 10.3760/cma.j.cn121430-20220727-00696.
9
Evaluation of CRUSADE and ACUITY-HORIZONS Scores for Predicting Long-term Out-of-Hospital Bleeding after Percutaneous Coronary Interventions.评价 CRUSADE 和 ACUITY-HORIZONS 评分对经皮冠状动脉介入治疗后长期院外出血的预测作用。
Chin Med J (Engl). 2018 Feb 5;131(3):262-267. doi: 10.4103/0366-6999.223858.
10
Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.通过糖化血红蛋白调整GRACE评分能够更准确地预测接受经皮冠状动脉介入治疗的非糖尿病急性冠状动脉综合征患者的长期主要不良心脏事件。
Cardiovasc Diabetol. 2015 Aug 19;14:110. doi: 10.1186/s12933-015-0274-4.

本文引用的文献

1
2023 ESC Guidelines for the management of acute coronary syndromes.2023年欧洲心脏病学会急性冠状动脉综合征管理指南。
Eur Heart J. 2023 Oct 12;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191.
2
Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation.在英国和瑞士人群中的非 ST 段抬高急性冠脉综合征中对 GRACE 评分进行性别特异性评估和重新开发:一项具有外部队列验证的多国分析。
Lancet. 2022 Sep 3;400(10354):744-756. doi: 10.1016/S0140-6736(22)01483-0. Epub 2022 Aug 29.
3
Diagnosis and Treatment of Acute Coronary Syndromes: A Review.
急性冠状动脉综合征的诊断与治疗:综述。
JAMA. 2022 Feb 15;327(7):662-675. doi: 10.1001/jama.2022.0358.
4
CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022.CVIT 专家共识文件:急性心肌梗死(AMI)直接经皮冠状动脉介入治疗(PCI)更新 2022 版
Cardiovasc Interv Ther. 2022 Jan;37(1):1-34. doi: 10.1007/s12928-021-00829-9. Epub 2022 Jan 12.
5
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 年 ACC/AHA/SCAI 冠状动脉血运重建指南:执行摘要:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
J Am Coll Cardiol. 2022 Jan 18;79(2):197-215. doi: 10.1016/j.jacc.2021.09.005. Epub 2021 Dec 9.
6
Comparison of Prognostic Value Among 4 Risk Scores in Patients with Acute Coronary Syndrome: Findings from the Improving Care for Cardiovascular Disease in China-ACS (CCC-ACS) Project.4 种风险评分在急性冠状动脉综合征患者中的预后价值比较:来自改善中国心血管疾病治疗-急性冠状动脉综合征(CCC-ACS)项目的研究结果。
Med Sci Monit. 2021 Mar 1;27:e928863. doi: 10.12659/MSM.928863.
7
ACEF performed better than other risk scores in non-ST-elevation acute coronary syndrome during long term follow-up.ACEF 在非 ST 段抬高型急性冠状动脉综合征的长期随访中优于其他风险评分。
BMC Cardiovasc Disord. 2021 Feb 3;21(1):70. doi: 10.1186/s12872-020-01841-2.
8
A LASSO-derived risk model for long-term mortality in Chinese patients with acute coronary syndrome.一种用于中国急性冠状动脉综合征患者长期死亡率的基于套索算法的风险模型。
J Transl Med. 2020 Apr 6;18(1):157. doi: 10.1186/s12967-020-02319-7.
9
Life Expectancy after Stroke Based On Age, Sex, and Rankin Grade of Disability: A Synthesis.基于年龄、性别和残疾等级的中风后预期寿命:综合评估。
J Stroke Cerebrovasc Dis. 2019 Dec;28(12):104450. doi: 10.1016/j.jstrokecerebrovasdis.2019.104450. Epub 2019 Oct 31.
10
Comparison of ACUITY, CRUSADE, and GRACE Risk Scales for Predicting Clinical Outcomes in Patients Treated with Dual-Antiplatelet Therapy.比较ACUITY、CRUSADE和GRACE风险量表在预测接受双联抗血小板治疗患者临床结局中的应用
TH Open. 2018 Nov 27;2(4):e399-e406. doi: 10.1055/s-0038-1675576. eCollection 2018 Oct.